Navigation Links
Sand dollar larvae use cloning to 'make change,' confound predators
Date:3/13/2008

Nature is full of examples of creatures that try to look as big as possible in an effort to scare away potential predators. But to avoid being eaten alive the larvae of sand dollars appear to have a different strategy, in a way exchanging a dollar for a couple of dimes.

University of Washington biologists have found that 4-day-old sand dollar larvae created clones of themselves within 24 hours of being exposed to fish mucous, a cue that predators are near. In each case, the cloning process resulted in a small new larva and the original larva substantially smaller than it had been.

The larvae responded to the general threat of predation rather than the immediate possibility of predator attack, said Dawn Vaughn, a UW biology doctoral student at the University of Washington's Friday Harbor Laboratories. The process caused the original larvae to shrink from about 300 microns, or about a hundredth of an inch, to about half that size, and the new larvae were even smaller.

"We think that by reducing their size they also reduce their visibility to predators," said Vaughn, who is lead author of a paper describing the work in the March 14 edition of Science.

Larval cloning has been observed previously among echinoderms, which include about 7,000 species of sea creatures, including starfish, sea urchins and sand dollars. However, this is the first time cloning by larvae has been seen as a survival mechanism in the face of possible predation.

The larvae of the sand dollar species Dendraster excentricus float as part of the plankton at various levels in open water, feeding as they slowly grow. After six weeks, the larvae reach a size of perhaps a three-hundredths of an inch and then settle to the ocean floor to finish developing to adulthood.

But as they float, the larvae are neither fast nor agile and have a high mortality rate, easily devoured by fish. Vaughn exposed 4-day-old larvae to fish mucous to see how th
'/>"/>

Contact: Vince Stricherz
vinces@u.washington.edu
206-543-2580
University of Washington
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
2. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
3. Does the desire to consume alcohol and tobacco come from our genetic makeup?
4. Bacteria from sponges make new pharmaceuticals
5. Extra gene copies were enough to make early humans mouths water
6. Nanotech could make solar energy as easy and cheap as growing grass
7. Scientists, policymakers and industry leaders gather to discuss ocean iron fertilization
8. Engineered eggshells to help make hydrogen fuel
9. New drug makes weight loss safer
10. Jumping genes could make for safer gene delivery system
11. Genetic differences in clover make one type toxic

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ts have at last worked out a way of using recordin...ird populations. This is the first time sound reco...d into accurate estimates of bird species, populat...ritish Ecological Society,s Journal of Applied Ec...ead to a major advance in our ability to monitor w...
(Date:11/26/2009)...thicillin-resistant Staphylococcus Aureus ) and o...on as low-temperature plasma prototype devices hav...failing bactericidal cocktails. , Two prototype ...infection of healthy skin (e.g. hands and feet) in...se a lethal threat; and another to shoot bacteria-...
(Date:11/25/2009)...mber 11, firefighters, police officers and ambulan... World Trade Center complex. They battled to save ...or survivors, tackled fires and evacuated as many ... estimated 17,000 people. And making their jobs ev...frightened workers and their relatives jammed mobi...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 1Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 2Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 3Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 4Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 5Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 6Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 1Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 2Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 3Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 4Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 5Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 6Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 7Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 8Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 1Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 2Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 3Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 4Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 5
...e believed to contain a toxic antimicrobial chemic...crutinized despite large scale,production and usag...sis conducted by researchers at the Johns Hopkins ...riclocarban, has been widely used for,decades in h...was,monitored for or detected in the environment. ...
...ease have surprised scientists with their ability ...brain plaques are removed.,Researchers at Washingt...cted mice with an antibody for a key component of ...n areas of the brain where,antibodies cleared plaq...nerve cell branches rapidly disappeared. , "These,...
...ease have surprised scientists with their ability ...brain plaques are removed.,Researchers at Washingt...cted mice with an antibody for a key component of ...n areas of the brain where,antibodies cleared plaq...nerve cell branches rapidly disappeared. , "These,...
Other Biology News:Anti-bacterial additive widespread in U.S. waterways 2Key molecule in plant photo-protection identified 2Key molecule in plant photo-protection identified 3Mouse brain cells rapidly recover after Alzheimer's plaques are cleared 2Mouse brain cells rapidly recover after Alzheimer's plaques are cleared 3
(Date:11/24/2009)...v. 24 Sigma-Aldrich Corp... NASDAQ OMX conference on Tuesday, December 1st at... parties may listen via live audio broadcast over ...g m a a ldrich.com/ . Users can click the "W...Sigma-Aldrich: Sigma-Aldrich is a leading Life S...
(Date:11/24/2009)...alif., Nov. 24 NeurogesX...ny focused on developing and commercializing novel...nthony DiTonno, President and Chief Executive Offi...per Jaffray Health Care Conference, to be held Dec...w York, New York. ,, Mr. DiTonno and Stephen G...
(Date:11/24/2009)...ficacy endpoint has been met for patients with adv...,, QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ ... (the "Company"), a global biopharmaceutical compa...y announced positive efficacy data from a Phase 2 ...e, AEZS-108 (formerly AN-152), in patients with ad...
(Date:11/24/2009)...Calif., Nov. 24 Genomic ... Randy Scott, Genomic Health,s Executive Chairman,...lth Care Conference in New York City on Tuesday, D... the live and subsequently archived webcast of the...n of Genomic Health,s website at http://investor....
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
..., , , , , , , Multip... , , Transformation Proto...01 , , , , , , ,... Organism , Neurospora crassa, ... Filamentous fungus, conidia, , ...
..., , , , , , , Multip..., , , , , , ...o. 4308 915.520 12/2001 , , , ..., , Microorganism , ... , Cell type , Bacteria, ...
..., , , , , , , Multip... , , Transfection Protoco... , , , , , , ,... Cell line , HeLa, human cervix epithel...Transfection with , Plasmid pEGFP-N1 (i...
Other Biology Technology:Neurospora crassa 2Listeria monocytogenes 2HeLa 2
Rabbit Anti-Human ADAM-12 (Meltrin alpha), carboxy terminal end Antibody, Unconjugated from CEDARLANE Laboratories Limited
Mouse Anti-hnRNP F / H Monoclonal Antibody, Unconjugated, Clone 1G11 from Novus Biologicals
Rabbit Anti-MKK6, phospho (Ser207) Polyclonal Antibody, Unconjugated from Abcam
Custom Oligo Assay Single Locus 1920 samples from Illumina
Biology Products: